Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Prostate Suppliers In Europe
67 companies found
based inSant Quirze del Vallès, SPAIN
INDIBA is a global leader in the field of Radio-Frequency (RF) solutions for the physiotherapy, aesthetic and veterinary market, and is known in the world for its scientific research performed in the last 35 years. Our ground-breaking technology ...
The CT9 device converts electrical current into a fixed stable frequency of 448 kHz, increasing ionic exchange at a cellular level which encourages tissue repair and assists in pain management. The return plate closes the electrical circuit, ...
based inRegensburg, GERMANY
numares is an innovative diagnostics company. We focus on the discovery, development and commercialization of diagnostic tests, using metabolite constellations to solve unmet medical needs that could not be addressed by single biomarker-based ...
Common cancers with established benefit of early diagnosis but for which there are no sensitive or specific tests are prostate, bladder and liver cancer1. Expensive imaging procedures are routinely required in clinical practice for ...
based inOxford, UNITED KINGDOM
Blue Earth Diagnostics is an established molecular imaging company on a growth trajectory to provide innovative, well differentiated diagnostics solutions, informing patients and driving future therapies in cancer. Formed in 2014, Blue Earth ...
The targeting molecule delivers a therapeutic dose of radiation to kill tumour cells. Blue Earth Diagnostics acquired exclusive, worldwide rights to radiohybrid Prostate Specific Membrane Antigen (rhPSMA) targeted technology in ...
based inFormello (Roma), ITALY
Futura System Group S.r.l. is an Italian company located in the suburbs of Rome that manufactures and distributes latest generation and high-quality in vitro diagnostics (I.V.D.) for Clinical Chemistry, Coagulation, Immunoturbidimetry , Serology and ...
Increasing kinetic colorimetric method according to Hillmann. Prefilled Buffer in 2 mL vials, Tartrate reagent liquid and ready to use, Substrate Fast Red as tablets to dissolve in the Buffer. Working Solution stability of 2 days at 2-8° C. ...
based inPlanegg, GERMANY
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines. At MorphoSys, our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical ...
Tulmimetostat is a second-generation EZH2 inhibitor that has been designed to achieve comprehensive target coverage through extended on-target residence time. EZH2 acts as an epigenetic writer and normally places one or more methyl groups on a ...
based inMilan, ITALY
Bracco is an international Group active in the healthcare sector and a leader in diagnostic imaging. It has around 3,587 employees and annual total consolidated revenues of around 1,4 billion euros, 89% of which from international sales. In the ...
based inSan Diego, CALIFORNIA (USA)
At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, ...
based inGrenoble, FRANCE
UroMems was founded in 2011 and focuses on designing, developing and commercializing active implantable medical devices. The company is based at the heart of the French Alps, in the city of Grenoble, representing one of the most dynamic French area ...
Stress urinary incontinence is defined as involuntary urinary leakage. It occurs when the pressure in the bladder exceeds that of the muscle (the sphincter) around the ...
based inNew York, NEW YORK (USA)
Stemline Therapeutics is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. The goal of our dedicated team of scientists, specialists, researchers, and developers is to build ...
XPO1 has been shown to regulate nuclear export of many of the major tumor suppressor proteins and oncogenic cell growth regulators. Overexpression of XPO1 has been reported in many cancer types and is associated with aggressive tumor behavior and ...
based inCham, SWITZERLAND
The global healthcare system is fundamentally changing - advances in technology such as robotics and artificial intelligence as well as rising consumer expectations are driving a global shift in the healthcare landscape. Similarly to the ...
Earlier, precise diagnostic of prostate cancer demands a paradigm change respectively a new treatment pathway. SONABLATE HIFU is the image-guided, non-invasive surgical ablation system that delivers precise, focused and controlled ...
based inOxford, UNITED KINGDOM
Vaccitech is a clinical stage T cell immunotherapy and vaccine company developing products to treat and prevent infectious disease and cancer. The company’s proprietary heterologous prime-boost platform comprises Chimpanzee Adenovirus Oxford ...
The patented Vaccitech adenovirus vectors are known as chimpanzee adenovirus Oxford 1 and 2 (ChAdOx1 and ChAdOx2), and are in the group E simian adenovirus family, similar to the widely-studied chimpanzee adenovirus 63. These viruses have been ...
based inSingapore, SINGAPORE
X-ZELL is fusing multi-channel immunostaining with digital single-cell imaging technology to enable same-day cancer diagnoses from minimally invasive body liquids – ready for routine cytology. X-ZELL is an award-winning medical technology company ...
based inIrvine, CALIFORNIA (USA)
MDxHealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on ...
ConfirmMDx Addresses Prostate Biopsy Sampling Error and the False-Negative Biopsy Dilemma. “Rule-in” high-risk men who have had a previous negative biopsy result, may be harboring undetected cancer (a false-negative ...
based inLa Tronche, FRANCE
INOVOTION is a Contract Research Laboratory implementing a unique approach to in vivo evaluation for anticancer drug discovery. Our cutting-edge proprietary technology provides early analysis of your compounds before the classical preclinical stage. ...
Pharmaceutical chemical and biology researchers need to develop new methods and models to improve the predictivity of preclinical discovery phases and increase the number of good molecules in clinic. INOVOTION’s unique in vivo technology ...
based inKobarid, SLOVENIA
TIK d.o.o., based in Kobarid, manufactures disposable medical devices. With its 60-year tradition, it is the largest manufacturer of such devices in Slovenia and wants to become a recognized manufacturer of medical devices in Europe and an ...
Use: For daily catheterisation, for short-term use for introduction through the urethra for urine drainage or therapeutic ...
based inStockholm, SWEDEN
As a leading innovator of precision radiation therapy solutions, Elekta is committed to ensuring that every patient has access to the best cancer care possible. At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical ...
Hypo-fractionated radiation therapy demands the highest levels of accuracy and precision. Versa HD Series with HDRS pushes the boundaries of your stereotactic capabilities. As evidence continues to grow for new radiosurgery indications ensure you ...
based inDresden, GERMANY
The company Samed GmbH Dresden is a company with a diverse range of services, which has developed from decades of experience in the medical field. Through close contact with doctors, both in the diagnostic and therapeutic fields, we are able to ...
The resection trainer LS10 series are suitable to learn and train all common resection ...
based inStafford, VIRGINIA (USA)
We are Hyper-accelerate drug and medical device development. Computational models and AI allow to dramatically accelerate the development of new drugs and medical devices, to reduce, refine and replace tests on animals and clinical trials, to ...
PCa GnRH Agonists Simulator enables simulations of clinical trials on a virtual population of prostate cancer patients being treated with a GnRH agonist ...
based inSolna, SWEDEN
Vivesto AB is a specialty pharmaceutical company focused on thedevelopment of new therapeutic options for patients suffering from hard-to-treatcancers. It has an emerging pipeline of clinical-stage assets targeting late-stagecancers. Apealea® ...
In June 2020, Vivesto partnered with the Swiss Group for Clinical Cancer Research (SAKK) with the aim of conducting the first clinical study on the treatment of metastasized prostate cancer with Vivesto’s Docetaxel micellar ...
based inSamarate, ITALY
Quanta System is a 100 Italian company that offers on the global market innovative laser systems for Surgery, Aesthetics and Art Conservation since 1985. In its headquarters in Varese (Samarate, Italy), the company employs 150 people and carries out ...
Cyber TM represents the family of high power Thulium laser (150W e 200W) dedicated to BPH and urology treatments, together with other soft tissue surgery in many other medical specialties. Its 2 μm radiation is strongly absorbed by water (highly ...